Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL6014509 | 0.98 | RIPK1 (0.53) | RIPK1TAAR1POLBTRPA1AOC3 | |
| Iodide SCHEMBL8983493 | 0.98 | RIPK1 (0.53) | RIPK1TAAR1POLBTRPA1AOC3 | |
| Hydrogen Peroxide SCHEMBL2352490 | 0.98 | RIPK1 (0.53) | RIPK1TAAR1POLBTRPA1AOC3 | |
| SCHEMBL598533 | 0.93 | RIPK1 (0.53) | RIPK1TAAR1POLBTRPA1AOC3 | |
| SCHEMBL27563798 | 0.92 | RIPK1 (0.48) | RIPK1TAAR1POLBTRPA1AOC3 | |
| SCHEMBL1299997 | 0.91 | RIPK1 (0.52) | RIPK1TAAR1POLBTRPA1AOC3 | |
| SCHEMBL508056 | 0.91 | RIPK1 (0.52) | RIPK1TAAR1POLBTRPA1AOC3 | |
| SCHEMBL16167034 | 0.91 | RIPK1 (0.52) | RIPK1TAAR1POLBTRPA1AOC3 | |
| SCHEMBL1412787 | 0.91 | RIPK1 (0.52) | RIPK1TAAR1POLBTRPA1AOC3 | |
| SCHEMBL9746665 | 0.91 | RIPK1 (0.52) | RIPK1TAAR1POLBTRPA1AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264111-A1 | A PROCESS FOR THE USE OF GLYOXYLIC AROMATIC CONDENSATES AS RE-TANNING AGENTS | STAHL INTERNATIONAL B.V. (NL) | 2025-12-26 | — | — | WO | claimed |
| US-20240026531-A1 | REFRACTORY CARBIDE LAYER | SGL CARBON SE (DE) | 2024-01-25 | — | — | US | claimed |
| EP-4259844-A1 | REFRACTORY CARBIDE LAYER | SGL Carbon SE (DE) | 2023-10-18 | — | — | EP | claimed |
| CN-116685724-A | Refractory carbide layer | 西格里碳素欧洲公司 | 2023-09-01 | — | — | CN | claimed |
| CN-114773506-A | Catalyst for in-situ nucleation of polypropylene and preparation method and application thereof | 山东京博石油化工有限公司 | 2022-07-22 | — | — | CN | claimed |
| WO-2022122877-A1 | REFRACTORY CARBIDE LAYER | SGL CARBON SE (DE) | 2022-06-16 | — | — | WO | claimed |
| EP-3778578-B1 | IMMUNOPROTEASOME INHIBITOR ANALOGS FOR TREATING INFLAMMATORY DISEASES | UNIV CALIFORNIA (US) | 2022-05-04 | — | — | EP | claimed |
| EP-3426641-B1 | IMMUNOPROTEASOME INHIBITOR ANALOGS | UNIV CALIFORNIA (US) | 2021-11-24 | — | — | EP | claimed |
| EP-3778578-A1 | IMMUNOPROTEASOME INHIBITOR ANALOGS FOR TREATING INFLAMMATORY DISEASES | The Regents of the University of California (US) | 2021-02-17 | — | — | EP | claimed |
| US-10584105-B2 | Immunoproteasome inhibitor analogs | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-03-10 | — | — | US | claimed |
| WO-2009010224-A1 | PROCESS FOR OXIDIZING ALKYLAROMATIC COMPOUNDS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-01-22 | — | — | WO | claimed |
| US-7446232-B2 | Process for oxidizing alkylaromatic compounds | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-11-04 | — | — | US | claimed |
| WO-2008018972-A2 | PROCESS FOR OXIDIZING ALKYLAROMATIC COMPOUNDS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-02-14 | — | — | WO | claimed |
| US-20080033217-A1 | Process for oxidizing alkylaromatic compounds | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-02-07 | — | — | US | claimed |
| US-5679878-A | CATALYTIC, VAPOR PHASE REACTION TO PRODUCE ALKYLSTYRENE BYDEHYDROGENATION OF TERTIARY BUTYLETHYLBENZENE | DELTECH CORPORATION (US) | 1997-10-21 | — | — | US | claimed |
| US-5436402-A | Reaction of o- or p-isobutylethylbenzene in the presence of a disproportionation acid catalyst and sec-butylethylbenzenne | NIPPON PETROCHEMICALS CO., LTD. (JP) | 1995-07-25 | — | — | US | claimed |
| EP-0373362-B1 | METHOD FOR PREPARING P-ISOBUTYLSTYRENE | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1993-02-03 | — | — | EP | claimed |
| EP-0373362-A1 | Method for preparing p-isobutylstyrene | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1990-06-20 | — | — | EP | claimed |
| US-4801758-A | OXIDATION, DIISOPROPYLBENZENE, ALKYLBENZENES, DECOMPOSITION OF DIHYDROPEROXIDE, ACID CATALYST | NESTE OY (FI) | 1989-01-31 | — | — | US | claimed |
| US-4532360-A | Oxidizing substituted benzene with molecular oxygen in presence of hydrogen bromide and boron phosphate, cerium oxide, triphenylborate and/or water | PHILLIPS PETROLEUM COMPANY (US) | 1985-07-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10584105-B2 | Immunoproteasome inhibitor analogs | PSMD8, PSMC5, PSMG3 | RIPK1 1244/4885TAAR1 4801/4885POLB 601/4885 |
| US-20080033217-A1 | Process for oxidizing alkylaromatic compounds | CBR1, CBR3, CYP2E1 | RIPK1 4222/4885TAAR1 212/4885POLB 574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.